Scientia Agricultura Sinica ›› 2012, Vol. 45 ›› Issue (2): 369-375.doi: 10.3864/j.issn.0578-1752.2012.02.020
• ANIMAL SCIENCE·RESOURCE INSECT • Previous Articles Next Articles
MIAO Xiang-Yang, CHEN Xiao-Ying
| [1]Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663-676.[2]Vogel G. Breakthrough of the year. Reprogramming cells. Science, 2008, 322(5909): 1766-1767.[3]Hanna J, Wernig M, Markoulaki S, Sun C W, Meissner A, Cassady J P, Beard C, Brambrink T, Wu L C, Townes T M, Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 2007, 318(5858): 1920-1923.[4]Zhao X Y, Li W, Lü Z, Liu L, Tong M, Hai T, Hao J, Guo C L, Ma Q W, Wang L, Zeng F Y, Zhou Q. iPS cells produce viable mice through tetraploid complementationnear-final version. Nature, 2009, 461(7260): 86-90.[5]Zhao Y, Yin X L, Qin H, Zhu F F, Liu H S, Yang W F, Zhang Q, Xiang C G, Hou P P, Song Z H, Liu Y X, Yong J, Zhang P B, Cai J, Liu M, Li H G, Li Y Q, Qu X X, Cui K, Zhang W Q, Xiang T T, Wu Y T, Zhao Y D, Liu C, Yu C, Yuan K H, Lou J N, Ding M X, Deng H K. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell, 2008, 3(5): 475-479.[6]Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee M J, Ji H, R. Ehrlich L I , Yabuuchi A, Takeuchi A, Cunniff K C, Hongguang H, Mckinney-Freeman S, Naveiras O, Yoon T J, Irizarry R A, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin S H, Weissman I L, Feinberg A P, Daley G Q. Epigenetic memory in induced pluripotent stem cells. Nature, 2010, 467: 285-290.[7]Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 2009, 458(7239): 771-775.[8]Sun N, Panetta N J, Gupta D M, Wilson K D, Lee A, Jia F J, Hu S J, Cherry A M, Robbins R C, Longaker M T, Wu J C. Feeder-free derivation of induced pluripot- ent stem cells from adult human adipose stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(37): 15720-15725.[9]Cai J, Li W, Su H, Qin D, Yang J, Zhu F, Xu J, He W, Guo H, Labuda K, Peterbauer A, Wolbank S, Zhong M, Li Z, Wu W, So KF, Redl H, Zeng L, Esteban M A, Pei D. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. The Journal of Biological Chemistry, 2010, 285(15): 11227-11234. [10]Zhao X Y, Li W, Lü Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Wang X, Wang L, Zeng F, Zhou Q. Efficient and rapid generation of induced pluripotent stem cells using alternative culture medium. Cell Research, 2010, 20(3): 383-386.[11]Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 2009, 5(3): 237-241.[12]Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322(5903): 945-949.[13]Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008, 322(5903): 949-953.[14]Woltjen K, Michael I P, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P T, Gertsenstein M, Kaji K, Sung Hoon-Ki, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009, 458(7329): 766-770. [15]Hasegawa K, Cowan A B, Nakatsuji N, Suemori H. Efficient multicistronic expression of a transgene in human embryonic stem cells. Stem Cells, 2007, 25(7): 1707-1712.[16]Szymczak A L, Workman C J, Wang Y, Vignali K M, Dilioglou S, Vanin E F, Vignali D A. Correction of multi-gene deficiency in vivo using a single‘self-cleaving’ 2A peptide-based retroviral vector. Nature Biotechnology, 2004, 22(5): 589-594.[17]Zhou H Y, Wu S L, Joo J Y, Zhu S Y, Han D W, Lin T X, Trauger S, Bien G, Yao S S, Zhu Y, Siuzdak G, Schöler H R, Duan L X, Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 2009, 4: 381-384.[18]Kim D, Kim C H, Moon J I, Chung Y G, Chang M Y, Han B S, Ko S, Yang E, Cha K Y, Lanza R, Kim K S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 2009, 4: 472-476.[19]Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology, 2009, 27(8): 743-745.[20]Ho P J, Yen M L, Lin J D, Chen L S, Hu H I, Yeh C K, Peng C Y, Lin C Y, Yet S F, Yen B L. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2. Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30(10): 1905-1907.[21]Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proceedings of the National Academy of Sciences of the United States of America, 2010,107(32): 14152-14157.[22]Stadtfeld M, Maherali N, Breault D T, Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell, 2008, 2(3): 230-240.[23]Mikkelsen T S, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein B E, Jaenisch R, Lander E S, Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature, 2008, 454(7200): 49-55.[24]Warren L, Manos P D, Ahfeldt T, Loh Y H, Li H, Lau F, Ebina W, Mandal P K, Smith Z D, Meissner A, Daley G Q, Brack A S, Collins J J, Cowan C, Schlaeger T M, Rossi De J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 2010, 7(5): 618-630.[25]Ezashi T, Telugu B P V L, Alexenko A P, Sachdev S, Sinha S, Roberts R M. Derivation of induced pluripotent stem cells from pig somatic cells. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(27): 10993-10998.[26]Wu Z, Chen J J, Ren J T, Bao L, Liao J, Cui C, Rao L J, Li H, Gu Y J, Dai H M, Zhu H, Teng X K, Cheng L, Xiao L. Generation of pig-induced pluripotent stem cells with a drug-inducible system. Journal of Molecular Cell Biology, 2009, 1(1): 46-54.[27]Li Y, Cang M, Lee A S, Zhang K, Liu D. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined. PLoS One 6:e15947 (2011).[28]Bao L, He L X Z, Chen J J, Wu Z, Liao J, Rao L J, Ren J T, Li H, Zhu H, Qian L, Gu Y J, Dai H M, Xu X, Zhou J Q, Wang W, Cui C, Xiao L. Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors. Cell Research, 2011, 21: 600-608.[29]Hanna J, Wernig M, Markoulaki S, Sun C W, Meissner A, Cassady J P, Beard C, Brambrink T, Wu L C, Townes T M, Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 2007, 318(5858): 1920-1923.[30]Ebert D, Yu J Y, Jr Rose F F, Mattis V B, Lorson C L, Thomson J A, Svendsen C N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 2009, 457(7227): 277-280.[31]Lee G, Papapetrou E P, Kim H, Chambers S M, Tomishima M J, Fasano C A, Ganat Y M, Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, Studer L. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 2009, 461(7262): 402-406.[32]Dimos J T, Rodolfa K T, Niakan K K, Weisentha l L M, Mitsumoto H, Chung W, Croft G F, Saphier G, Leibel R, Goland R, Wichterle H, Henderson C E, Eggan K. Induced pluripotent stem cells generat-ed from patients with ALS can be differentiated into motor neurons. Science, 2008, 321(5893): 1218-1221.[33]Park I H, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch M W, Cowan C, Hochedlinger K, Daley G Q. Disease-specific induced pluripotent stem cells. Cell, 2008, 134(5): 877-886.[34]Soldner F, Hockemeyer D, Beard C, Gao Q, Bell G W, Cook E G, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136(5): 964-977.[35]Rashid S T, Corbineau S, Hannan N, Marciniak S J, Miranda E, Alexander G, Huang-Doran I, Griffin J, Ahrlund-Richter L, Skepper J, Semple R, Weber A, Lomas D A, Vallier L. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. The Jouranl of Clinical Investigation, 2010, 120(90): 3127-3136.[36]Noritaka Y, Shiro B, Shinji K, Akira N, Takahiro M, Hiraku D, Shinya Y, Tatsutoshi N, Toshio H. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochemical and Biophysical Research Communications, 2009, 387(3): 482-488. |
| [1] | DU Jun-Hui, CAO Wen-Guang. Advances in Differentiation of iPS Cells into Male Germ Cells [J]. Scientia Agricultura Sinica, 2014, 47(16): 3308-3314. |
|
||